• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factors associated with undiagnosed and overdiagnosed COPD.

作者信息

Gershon Andrea S, Hwee Jeremiah, Chapman Kenneth R, Aaron Shawn D, O'Donnell Denis E, Stanbrook Matthew B, Bourbeau Jean, Tan Wan, Su Jiandong, Victor J Charles, To Teresa

机构信息

Dept of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Institute for Clinical Evaluative Sciences, Toronto, ON, Canada Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada The Hospital for Sick Children, Toronto, ON, Canada

Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.

出版信息

Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23.

DOI:10.1183/13993003.00458-2016
PMID:27338199
Abstract
摘要

相似文献

1
Factors associated with undiagnosed and overdiagnosed COPD.与慢性阻塞性肺疾病未确诊和过度诊断相关的因素。
Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23.
2
Health Services Burden of Undiagnosed and Overdiagnosed COPD.未诊断和过度诊断 COPD 的卫生服务负担。
Chest. 2018 Jun;153(6):1336-1346. doi: 10.1016/j.chest.2018.01.038. Epub 2018 Feb 6.
3
Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction.在肺功能测试显示无阻塞后仍持续进行经验性慢性阻塞性肺疾病的诊断和治疗。
Respir Care. 2016 Sep;61(9):1192-200. doi: 10.4187/respcare.04647. Epub 2016 May 10.
4
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history.急性冠状动脉综合征且有吸烟史患者出院前慢性阻塞性肺疾病筛查
Int J Cardiol. 2016 Nov 1;222:806-812. doi: 10.1016/j.ijcard.2016.08.030. Epub 2016 Aug 4.
5
Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.40岁及以上初级保健患者中慢性阻塞性肺疾病（COPD）和哮喘的误诊情况。
J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738.
6
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.新诊断的慢性阻塞性肺疾病。慢性阻塞性肺疾病全球倡议新分期的临床特征及分布情况
Respiration. 2003 Jan-Feb;70(1):67-75. doi: 10.1159/000068417.
7
High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at first hospital admission with acute exacerbation.高患病率的未诊断和严重的慢性阻塞性肺疾病首次住院急性加重。
Chron Respir Dis. 2010;7(2):91-7. doi: 10.1177/1479972310364587. Epub 2010 Mar 18.
8
Patient and physician factors associated with pulmonary function testing for COPD: a population study.与 COPD 肺功能测试相关的患者和医生因素：一项人群研究。
Chest. 2014 Feb;145(2):272-281. doi: 10.1378/chest.13-0790.
9
Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking.我们是否需要为慢性阻塞性肺疾病（COPD）吸烟者量身定制戒烟干预措施？一项针对有和没有COPD的吸烟者与吸烟相关因素的比较研究。
Respiration. 2015;90(3):211-9. doi: 10.1159/000398816. Epub 2015 May 28.
10
Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.美国未确诊的阻塞性肺病：相关因素及长期死亡率
Ann Am Thorac Soc. 2015 Dec;12(12):1788-95. doi: 10.1513/AnnalsATS.201506-388OC.

引用本文的文献

1
A stepwise approach for pharmacists in selecting climate-conscious inhaled therapy for COPD.药剂师为慢性阻塞性肺疾病（COPD）选择具有气候意识的吸入疗法的逐步方法。
Can Pharm J (Ott). 2024 Nov 15;158(1):12-19. doi: 10.1177/17151635241273754. eCollection 2025 Jan-Feb.
2
Sensitivity of major chronic diseases and patients of different ages to the collapse of the healthcare system during the COVID-19 pandemic in China.中国 COVID-19 大流行期间主要慢性疾病和不同年龄患者对医疗体系崩溃的敏感性。
Medicine (Baltimore). 2024 Nov 29;103(48):e40730. doi: 10.1097/MD.0000000000040730.
3
Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy.
消除初级保健中慢性阻塞性肺疾病管理的障碍：应用2023年更新的加拿大胸科学会药物治疗指南
Front Med (Lausanne). 2024 Aug 6;11:1416163. doi: 10.3389/fmed.2024.1416163. eCollection 2024.
4
Access to Treatment for Chronic Obstructive Pulmonary Disease in the Americas: A Call for Action. A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and the American Thoracic Society.美洲慢性阻塞性肺疾病的治疗可及性：行动呼吁。巴西胸科学会、加拿大胸科学会、拉丁美洲胸科学会和美国胸科学会的联合观点。
Ann Am Thorac Soc. 2024 Nov;21(11):1463-1470. doi: 10.1513/AnnalsATS.202404-386FR.
5
Mild antecedent COVID-19 associated with symptom-specific post-acute sequelae.轻度前驱 COVID-19 与症状特异性急性后遗留症状相关。
PLoS One. 2023 Jul 10;18(7):e0288391. doi: 10.1371/journal.pone.0288391. eCollection 2023.
6
Comparison of the lower limit of normal to the fixed ratio method for the diagnosis of airflow obstruction at high altitudes: a large cross-sectional survey of subjects living between 3000-4700 m above sea level.比较正常下限与固定比值法在高海拔地区气流阻塞诊断中的应用：居住在海拔 3000-4700 米以上人群的大型横断面研究。
Eur J Med Res. 2023 Jun 12;28(1):189. doi: 10.1186/s40001-023-01151-1.
7
Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study.香烟、电子烟使用与慢性阻塞性肺疾病发病：一项前瞻性纵向研究。
Am J Prev Med. 2023 Aug;65(2):173-181. doi: 10.1016/j.amepre.2023.01.038. Epub 2023 Mar 7.
8
Transcutaneous electrical nerve stimulation over acupoint for chronic obstructive pulmonary disease: A systematic review and meta-analysis.经皮穴位电刺激治疗慢性阻塞性肺疾病的系统评价和荟萃分析。
Front Public Health. 2022 Oct 6;10:937835. doi: 10.3389/fpubh.2022.937835. eCollection 2022.
9
Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.吸烟与慢性阻塞性肺疾病（COPD）流行率及发病率的相关性研究：基于人群评估烟草和健康（PATH）研究的第 1 至 5 波（2013-2019 年）。
Respir Res. 2022 Oct 1;23(1):273. doi: 10.1186/s12931-022-02197-1.
10
[Not Available].[无可用内容]
Can Fam Physician. 2022 Jun;68(6):441-444. doi: 10.46747/cfp.6806441.